Page last updated: 2024-08-21

thymoquinone and Carcinoma, Small Cell Lung

thymoquinone has been researched along with Carcinoma, Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glass, J; Jafri, SH; Kleiner-Hancock, H; Prince, M; Shi, R; Zhang, S	1

Other Studies

1 other study(ies) available for thymoquinone and Carcinoma, Small Cell Lung

Article	Year
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo. Journal of experimental & clinical cancer research : CR, 2010, Jul-01, Volume: 29 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Lipopolysaccharides; Lung Neoplasms; Maximum Tolerated Dose; Mice; Mice, SCID; Mice, Transgenic; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2010

Article

Year

Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.

Journal of experimental & clinical cancer research : CR, 2010, Jul-01, Volume: 29

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Lipopolysaccharides; Lung Neoplasms; Maximum Tolerated Dose; Mice; Mice, SCID; Mice, Transgenic; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010